Buccal Drug Delivery System Market Size, Share, Revenue, Trends, and Drivers For 2024-2033

Buccal Drug Delivery System Market Size, Share, Revenue, Trends, and Drivers For 2024-2033

LONDON, GREATER LONDON, UNITED KINGDOM, October 31, 2024 /EINPresswire.com/ — The buccal drug delivery system market has experienced robust growth in recent years, expanding from $3.28 billion in 2023 to $3.64 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.

What Is The Estimated Market Size Of The Global Buccal Drug Delivery System Market And Its Annual Growth Rate?
The buccal drug delivery system market is projected to continue its strong growth, reaching $5.43 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d.

Explore Comprehensive Insights Into The Global Buccal Drug Delivery System Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=8290&type=smp

Growth Driver Of The Buccal Drug Delivery System Market
The Increasing demand in hospitals is expected to propel the growth of the buccal drug delivery systems market going forward. A hospital is a specialized facility designed to provide medical treatment, care, and services to individuals who are sick or injured. Buccal drug delivery systems in hospital settings offer rapid drug absorption, improved patient compliance, reduce GI side effects, and provide a controlled release of drugs.

Make Your Report Purchase Here And Explore The Whole Industry’s Data As Well:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report

Who Are The Leading Competitors In The Buccal Drug Delivery System Market Share?
Key players in the market include Teva Pharmaceuticals Industries Ltd., Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior plc, Generex Biotechnology Corporation, Catalent Inc., Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd., AstraZeneca plc, F Hoffmann-La Roche Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Novartis AG, Novo Nordisk A/S, Ethypharm SAS, Applied Pharma Research SA, Sunovion Pharmaceuticals Inc., Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc., NAPP Pharmaceutical Ltd., Perrigo Company plc, Reckitt Benckiser Group plc, Teligent Pharma Inc., Par Pharmaceutical Companies Inc., Acorda Therapeutics Inc., Opiant Pharmaceuticals Inc.

What Are The Dominant Trends In Buccal Drug Delivery System Market Growth?
Major companies operating in the buccal drug delivery systems market are focusing on products launches, such as melatonin oral spray, to drive revenues in their market. Melatonin oral spray is a form of melatonin supplementation that comes in a spray format for oral use.

How Is The Global Buccal Drug Delivery System Market Segmented?
1) By Type: Sublingual, Buccal Tablets and Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cesstion, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users

Geographical Insights: North America Leading The Buccal Drug Delivery System Market
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Buccal Drug Delivery System Market Definition
The buccal drug delivery system refers to the injection of the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for administering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

Buccal Drug Delivery System Global Market Report 2024 from The Business Research Company covers the following information:
• Market size data for the forecast period: Historical and Future
• Macroeconomic factors affecting the market in the short and long run
• Analysis of the macro and micro economic factors that have affected the market in the past five years
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

An overview of the global buccal drug delivery system market report covering trends, opportunities, strategies, and more
The Buccal Drug Delivery System Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on buccal drug delivery system market size, buccal drug delivery system market drivers and trends, buccal drug delivery system market major players and buccal drug delivery system market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:

Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Implantable Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Microneedle Drug Delivery Systems Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/microneedle-drug-delivery-systems-global-market-report

What Does the Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.